Efg Capital International Corp. »

Blueprint Medicines shares owned by Efg Capital International Corp.

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Efg Capital International Corp. from 13F filings

Historical chart of Efg Capital International Corp. investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by Efg Capital International Corp. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by Efg Capital International Corp.

Quarter filed Position value Share count Share price at filing
2023-06-30 $348k 5.5k 63.20

More positions owned by Efg Capital International Corp.

Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Apple (AAPL)
Amazon (AMZN)
Mastercard Incorporated Cl A (MA)
UnitedHealth (UNH)
Verisk Analytics (VRSK)
Alphabet Cap Stk Cl C (GOOG)
Johnson & Johnson (JNJ)
Pepsi (PEP)
Cme (CME)
Adobe Systems Incorporated (ADBE)
Tesla Motors (TSLA)
Netflix (NFLX)
JPMorgan Chase & Co. (JPM)

View all positions for Efg Capital International Corp.

Top funds holding Blueprint Medicines

BlackRock
Vanguard Group
T. Rowe Price Associates
FMR
Wellington Management Company
State Street Corporation
Jane Street
William Blair Investment Management
Geode Capital Management
Macquarie Group
Jpmorgan Chase & Co
Alliancebernstein
Lord, Abbett & Co
Pictet Asset Management Holding SA
Invesco

View all funds holding Blueprint Medicines